References in periodicals archive ?
"There are other things that can influence your triglycerides, but for the most part they're highly related to your diet," says Julia Zumpano, RD, LD, a dietitian with Cleveland Clinic's Department of Preventive Cardiology and Cardiac Rehabilitation.
Although several studies have shown fasting triglyceride levels to be associated with Coronary artery disease in both diabetic and non-diabetic subjects, relatively little attention has been given to postprandial triglycerides in this regard, especially in diabetic subjects.
The work began several years ago when researchers at the Broad Institute of Harvard and MIT starting searching through an enormous data set drawn from 70 studies involving 200,000 people to see if there were tiny genetic changes near or in genes that seemed to lead to very high or very low amounts of triglycerides in the blood.
* The three drug classes that reduce triglycerides (fibrates, niacin, and n-3 fatty acids) alone or in combination with statins may be considered as treatment options in patients with moderate to severe bypertriglyceridemia.
Q: Do triglycerides end up in the plaque that clogs arteries?
The stroke danger associated with high triglyceride levels was revealed in a large study published in the April 2011 issue of Annals of Neurology.
"From our review of the evidence from 17 randomised, controlled clinical trials on high triglyceride levels, we concluded that treatment with 4 grams daily of any of the available prescription choices is effective and can be used safely in conjunction with statin medicines that lower cholesterol," said Ann Skulas-Ray, an author of the study.
"The importance of managing triglycerides cannot be underestimated," Hirsh said.
For the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate of Medium-chain Triglycerides for each application, including
"We are increasingly recognizing that elevated triglycerides represent a major issue and should not be ignored," says Steven Nissen, MD, chairman of Cardiovascular Medicine at Cleveland Clinic."